APO Research
Talk to an analyst

APO RESEARCH · REPORT

Custom Recombinant Antibody Conversion Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Custom Recombinant Antibody Conversion Service Industry Growth and Trends Forecast to 2032

11 April 2026113 pages

Choose your research edition.

Industry ResearchCustom Recombinant Antibody Conversion Service Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Custom Recombinant Antibody Conversion Service Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Custom Recombinant Antibody Conversion Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Custom Recombinant Antibody Conversion Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Custom Recombinant Antibody Conversion Service Market Analysis and Forecast 2026-2032258 pages · $4,950 USD

Market perspective

According to APO Research, the global Custom Recombinant Antibody Conversion Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Custom Recombinant Antibody Conversion Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Custom Recombinant Antibody Conversion Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Custom Recombinant Antibody Conversion Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Custom Recombinant Antibody Conversion Service market include Creative Biolabs, Abnova Corporation, GenScript Biotech Corporation, Rockland Immunochemicals Inc., LakePharma Inc., ProteoGenix, ProMab Biotechnologies Inc., Sino Biological Inc. and BOC Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Custom Recombinant Antibody Conversion Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Custom Recombinant Antibody Conversion Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Custom Recombinant Antibody Conversion Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Custom Recombinant Antibody Conversion Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Custom Recombinant Antibody Conversion Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Custom Recombinant Antibody Conversion Service Market by Company

Creative Biolabs

Abnova Corporation

GenScript Biotech Corporation

Rockland Immunochemicals Inc.

LakePharma Inc.

ProteoGenix

ProMab Biotechnologies Inc.

Sino Biological Inc.

BOC Sciences

Absolute Antibody Ltd.

OriGene Technologies Inc.

Novus Biologicals LLC

BioLegend Inc.

RayBiotech Inc.

Proteintech Group Inc.

ACROBiosystems

Custom Recombinant Antibody Conversion Service Segment by Type

Fab and scFv Antibody Fragment Production

Chimeric Antibody Production

Bispecific Antibody Production

Antibody Labeling and Conjugation

Custom Recombinant Antibody Conversion Service Segment by Application

Research and Development

Diagnostics

Therapeutics

Biomanufacturing

Agriculture and Food

Others

Custom Recombinant Antibody Conversion Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Recombinant Antibody Conversion Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Recombinant Antibody Conversion Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Recombinant Antibody Conversion Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Custom Recombinant Antibody Conversion Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Custom Recombinant Antibody Conversion Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Custom Recombinant Antibody Conversion Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Custom Recombinant Antibody Conversion Service Market Share by Region (2021-2026) Table 4. Global Custom Recombinant Antibody Conversion Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Custom Recombinant Antibody Conversion Service Market Share by Region (2027-2032) Table 6. Global Custom Recombinant Antibody Conversion Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Custom Recombinant Antibody Conversion Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Custom Recombinant Antibody Conversion Service Market Size Share by Type (2021-2026) Table 9. Global Custom Recombinant Antibody Conversion Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Custom Recombinant Antibody Conversion Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Custom Recombinant Antibody Conversion Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Custom Recombinant Antibody Conversion Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Custom Recombinant Antibody Conversion Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Custom Recombinant Antibody Conversion Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Custom Recombinant Antibody Conversion Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Custom Recombinant Antibody Conversion Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Custom Recombinant Antibody Conversion Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Custom Recombinant Antibody Conversion Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Custom Recombinant Antibody Conversion Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Custom Recombinant Antibody Conversion Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Custom Recombinant Antibody Conversion Service Market Size Share by Application (2021-2026) Table 24. Global Custom Recombinant Antibody Conversion Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Custom Recombinant Antibody Conversion Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Custom Recombinant Antibody Conversion Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Custom Recombinant Antibody Conversion Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Custom Recombinant Antibody Conversion Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Custom Recombinant Antibody Conversion Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Custom Recombinant Antibody Conversion Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Custom Recombinant Antibody Conversion Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Custom Recombinant Antibody Conversion Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Custom Recombinant Antibody Conversion Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Custom Recombinant Antibody Conversion Service Industry Trends Table 37. Custom Recombinant Antibody Conversion Service Industry Drivers Table 38. Custom Recombinant Antibody Conversion Service Industry Opportunities and Challenges Table 39. Custom Recombinant Antibody Conversion Service Industry Restraints Table 40. Global Custom Recombinant Antibody Conversion Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Custom Recombinant Antibody Conversion Service Revenue Market Share by Company (2021-2026) Table 42. Global Custom Recombinant Antibody Conversion Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Custom Recombinant Antibody Conversion Service Key Company Headquarters & Area Served Table 44. Global Custom Recombinant Antibody Conversion Service Company, Product Type & Application Table 45. Global Custom Recombinant Antibody Conversion Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Custom Recombinant Antibody Conversion Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Creative Biolabs Company Information Table 49. Creative Biolabs Business Overview Table 50. Creative Biolabs Custom Recombinant Antibody Conversion Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Creative Biolabs Custom Recombinant Antibody Conversion Service Product Portfolio Table 52. Creative Biolabs Recent Development Table 53. Abnova Corporation Company Information Table 54. Abnova Corporation Business Overview Table 55. Abnova Corporation Custom Recombinant Antibody Conversion Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Abnova Corporation Custom Recombinant Antibody Conversion Service Product Portfolio Table 57. Abnova Corporation Recent Development Table 58. GenScript Biotech Corporation Company Information Table 59. GenScript Biotech Corporation Business Overview Table 60. GenScript Biotech Corporation Custom Recombinant Antibody Conversion Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. GenScript Biotech Corporation Custom Recombinant Antibody Conversion Service Product Portfolio Table 62. GenScript Biotech Corporation Recent Development Table 63. Rockland Immunochemicals Inc. Company Information Table 64. Rockland Immunochemicals Inc. Business Overview Table 65. Rockland Immunochemicals Inc. Custom Recombinant Antibody Conversion Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Rockland Immunochemicals Inc. Custom Recombinant Antibody Conversion Service Product Portfolio Table 67. Rockland Immunochemicals Inc. Recent Development Table 68. LakePharma Inc. Company Information Table 69. LakePharma Inc. Business Overview Table 70. LakePharma Inc. Custom Recombinant Antibody Conversion Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. LakePharma Inc. Custom Recombinant Antibody Conversion Service Product Portfolio Table 72. LakePharma Inc. Recent Development Table 73. ProteoGenix Company Information Table 74. ProteoGenix Business Overview Table 75. ProteoGenix Custom Recombinant Antibody Conversion Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. ProteoGenix Custom Recombinant Antibody Conversion Service Product Portfolio Table 77. ProteoGenix Recent Development Table 78. ProMab Biotechnologies Inc. Company Information Table 79. ProMab Biotechnologies Inc. Business Overview Table 80. ProMab Biotechnologies Inc. Custom Recombinant Antibody Conversion Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. ProMab Biotechnologies Inc. Custom Recombinant Antibody Conversion Service Product Portfolio Table 82. ProMab Biotechnologies Inc. Recent Development Table 83. Sino Biological Inc. Company Information Table 84. Sino Biological Inc. Business Overview Table 85. Sino Biological Inc. Custom Recombinant Antibody Conversion Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Sino Biological Inc. Custom Recombinant Antibody Conversion Service Product Portfolio Table 87. Sino Biological Inc. Recent Development Table 88. BOC Sciences Company Information Table 89. BOC Sciences Business Overview Table 90. BOC Sciences Custom Recombinant Antibody Conversion Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. BOC Sciences Custom Recombinant Antibody Conversion Service Product Portfolio Table 92. BOC Sciences Recent Development Table 93. Absolute Antibody Ltd. Company Information Table 94. Absolute Antibody Ltd. Business Overview Table 95. Absolute Antibody Ltd. Custom Recombinant Antibody Conversion Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Absolute Antibody Ltd. Custom Recombinant Antibody Conversion Service Product Portfolio Table 97. Absolute Antibody Ltd. Recent Development Table 98. OriGene Technologies Inc. Company Information Table 99. OriGene Technologies Inc. Business Overview Table 100. OriGene Technologies Inc. Custom Recombinant Antibody Conversion Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. OriGene Technologies Inc. Custom Recombinant Antibody Conversion Service Product Portfolio Table 102. OriGene Technologies Inc. Recent Development Table 103. Novus Biologicals LLC Company Information Table 104. Novus Biologicals LLC Business Overview Table 105. Novus Biologicals LLC Custom Recombinant Antibody Conversion Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Novus Biologicals LLC Custom Recombinant Antibody Conversion Service Product Portfolio Table 107. Novus Biologicals LLC Recent Development Table 108. BioLegend Inc. Company Information Table 109. BioLegend Inc. Business Overview Table 110. BioLegend Inc. Custom Recombinant Antibody Conversion Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. BioLegend Inc. Custom Recombinant Antibody Conversion Service Product Portfolio Table 112. BioLegend Inc. Recent Development Table 113. RayBiotech Inc. Company Information Table 114. RayBiotech Inc. Business Overview Table 115. RayBiotech Inc. Custom Recombinant Antibody Conversion Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. RayBiotech Inc. Custom Recombinant Antibody Conversion Service Product Portfolio Table 117. RayBiotech Inc. Recent Development Table 118. Proteintech Group Inc. Company Information Table 119. Proteintech Group Inc. Business Overview Table 120. Proteintech Group Inc. Custom Recombinant Antibody Conversion Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Proteintech Group Inc. Custom Recombinant Antibody Conversion Service Product Portfolio Table 122. Proteintech Group Inc. Recent Development Table 123. ACROBiosystems Company Information Table 124. ACROBiosystems Business Overview Table 125. ACROBiosystems Custom Recombinant Antibody Conversion Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. ACROBiosystems Custom Recombinant Antibody Conversion Service Product Portfolio Table 127. ACROBiosystems Recent Development Table 128. North America Custom Recombinant Antibody Conversion Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Custom Recombinant Antibody Conversion Service Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Custom Recombinant Antibody Conversion Service Market Share by Country (2021-2026) Table 131. North America Custom Recombinant Antibody Conversion Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Custom Recombinant Antibody Conversion Service Market Share Forecast by Country (2027-2032) Table 133. Europe Custom Recombinant Antibody Conversion Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Custom Recombinant Antibody Conversion Service Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Custom Recombinant Antibody Conversion Service Market Share by Country (2021-2026) Table 136. Europe Custom Recombinant Antibody Conversion Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Custom Recombinant Antibody Conversion Service Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Custom Recombinant Antibody Conversion Service Market Share by Country (2021-2026) Table 141. Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Custom Recombinant Antibody Conversion Service Market Share Forecast by Country (2027-2032) Table 143. Latin America Custom Recombinant Antibody Conversion Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Custom Recombinant Antibody Conversion Service Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Custom Recombinant Antibody Conversion Service Market Share by Country (2021-2026) Table 146. Latin America Custom Recombinant Antibody Conversion Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Custom Recombinant Antibody Conversion Service Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Custom Recombinant Antibody Conversion Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Custom Recombinant Antibody Conversion Service Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Custom Recombinant Antibody Conversion Service Market Share by Country (2021-2026) Table 151. Middle East & Africa Custom Recombinant Antibody Conversion Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Custom Recombinant Antibody Conversion Service Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Custom Recombinant Antibody Conversion Service Product Image Figure 3. Global Custom Recombinant Antibody Conversion Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Custom Recombinant Antibody Conversion Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Custom Recombinant Antibody Conversion Service Market Share by Region: 2025 VS 2032 Figure 6. Global Custom Recombinant Antibody Conversion Service Market Share by Region (2021-2032) Figure 7. North America Custom Recombinant Antibody Conversion Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Custom Recombinant Antibody Conversion Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Custom Recombinant Antibody Conversion Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Custom Recombinant Antibody Conversion Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Fab and scFv Antibody Fragment Production Image Figure 13. Global Fab and scFv Antibody Fragment Production Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Chimeric Antibody Production Image Figure 15. Global Chimeric Antibody Production Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Bispecific Antibody Production Image Figure 17. Global Bispecific Antibody Production Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Antibody Labeling and Conjugation Image Figure 19. Global Antibody Labeling and Conjugation Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Custom Recombinant Antibody Conversion Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Custom Recombinant Antibody Conversion Service Market Share by Type 2025 VS 2032 Figure 22. North America Custom Recombinant Antibody Conversion Service Market Size Share by Type (2021-2032) Figure 23. Europe Custom Recombinant Antibody Conversion Service Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size Share by Type (2021-2032) Figure 25. Latin America Custom Recombinant Antibody Conversion Service Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Custom Recombinant Antibody Conversion Service Market Size Share by Type (2021-2032) Figure 27. Research and Development Image Figure 28. Global Research and Development Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Diagnostics Image Figure 30. Global Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Therapeutics Image Figure 32. Global Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Biomanufacturing Image Figure 34. Global Biomanufacturing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Agriculture and Food Image Figure 36. Global Agriculture and Food Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Others Image Figure 38. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global Custom Recombinant Antibody Conversion Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Custom Recombinant Antibody Conversion Service Market Share by Application 2025 VS 2032 Figure 41. North America Custom Recombinant Antibody Conversion Service Market Size Share by Application (2021-2032) Figure 42. Europe Custom Recombinant Antibody Conversion Service Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size Share by Application (2021-2032) Figure 44. Latin America Custom Recombinant Antibody Conversion Service Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa Custom Recombinant Antibody Conversion Service Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 Custom Recombinant Antibody Conversion Service Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America Custom Recombinant Antibody Conversion Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America Custom Recombinant Antibody Conversion Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America Custom Recombinant Antibody Conversion Service Market Share by Country (2021-2032) Figure 51. Europe Custom Recombinant Antibody Conversion Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Custom Recombinant Antibody Conversion Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Custom Recombinant Antibody Conversion Service Market Share by Country (2021-2032) Figure 54. Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific Custom Recombinant Antibody Conversion Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific Custom Recombinant Antibody Conversion Service Market Share by Country (2021-2032) Figure 57. Latin America Custom Recombinant Antibody Conversion Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Custom Recombinant Antibody Conversion Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Custom Recombinant Antibody Conversion Service Market Share by Country (2021-2032) Figure 60. Middle East & Africa Custom Recombinant Antibody Conversion Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa Custom Recombinant Antibody Conversion Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa Custom Recombinant Antibody Conversion Service Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Fab and scFv Antibody Fragment Production
  • Chimeric Antibody Production
  • Bispecific Antibody Production
  • Antibody Labeling and Conjugation
Applications
  • Research and Development
  • Diagnostics
  • Therapeutics
  • Biomanufacturing
  • Agriculture and Food
  • Others
Companies covered
  • Creative Biolabs
  • Abnova Corporation
  • GenScript Biotech Corporation
  • Rockland Immunochemicals Inc.
  • LakePharma Inc.
  • ProteoGenix
  • ProMab Biotechnologies Inc.
  • Sino Biological Inc.
  • BOC Sciences
  • Absolute Antibody Ltd.
  • OriGene Technologies Inc.
  • Novus Biologicals LLC
  • BioLegend Inc.
  • RayBiotech Inc.
  • Proteintech Group Inc.
  • ACROBiosystems

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Custom Recombinant Antibody Conversion Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Custom Recombinant Antibody Conversion Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Custom Recombinant Antibody Conversion Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Custom Recombinant Antibody Conversion Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Custom Recombinant Antibody Conversion Service Market Size (2021-2032)
  8. 1.5.1 North America Custom Recombinant Antibody Conversion Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Custom Recombinant Antibody Conversion Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Custom Recombinant Antibody Conversion Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Custom Recombinant Antibody Conversion Service Market Size Growth Rate (2021-2032)
2 Custom Recombinant Antibody Conversion Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Fab and scFv Antibody Fragment Production
  3. 2.1.2 Chimeric Antibody Production
  4. 2.1.3 Bispecific Antibody Production
  5. 2.1.4 Antibody Labeling and Conjugation
  6. 2.2 Global Custom Recombinant Antibody Conversion Service Market Size by Type
  7. 2.2.1 Global Custom Recombinant Antibody Conversion Service Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Custom Recombinant Antibody Conversion Service Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Custom Recombinant Antibody Conversion Service Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Custom Recombinant Antibody Conversion Service Market Size by Regions
  11. 2.3.1 North America Custom Recombinant Antibody Conversion Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Custom Recombinant Antibody Conversion Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Custom Recombinant Antibody Conversion Service Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Custom Recombinant Antibody Conversion Service Market Size Breakdown by Type (2021-2026)
3 Custom Recombinant Antibody Conversion Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Research and Development
  3. 3.1.2 Diagnostics
  4. 3.1.3 Therapeutics
  5. 3.1.4 Biomanufacturing
  6. 3.1.5 Agriculture and Food
  7. 3.1.6 Others
  8. 3.2 Global Custom Recombinant Antibody Conversion Service Market Size by Application
  9. 3.2.1 Global Custom Recombinant Antibody Conversion Service Market Size Overview by Application (2021-2032)
  10. 3.2.2 Global Custom Recombinant Antibody Conversion Service Historic Market Size Review by Application (2021-2026)
  11. 3.2.3 Global Custom Recombinant Antibody Conversion Service Market Size Forecasted by Application (2027-2032)
  12. 3.3 Global Custom Recombinant Antibody Conversion Service Market Size by Regions
  13. 3.3.1 North America Custom Recombinant Antibody Conversion Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.2 Europe Custom Recombinant Antibody Conversion Service Market Size Breakdown by Application (2021-2026)
  15. 3.3.3 Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size Breakdown by Application (2021-2026)
  16. 3.3.4 South America Custom Recombinant Antibody Conversion Service Market Size Breakdown by Application (2021-2026)
  17. 3.3.5 Middle East and Africa Custom Recombinant Antibody Conversion Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Custom Recombinant Antibody Conversion Service Industry Trends
  2. 4.2 Custom Recombinant Antibody Conversion Service Industry Drivers
  3. 4.3 Custom Recombinant Antibody Conversion Service Industry Opportunities and Challenges
  4. 4.4 Custom Recombinant Antibody Conversion Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Custom Recombinant Antibody Conversion Service Revenue (2021-2026)
  2. 5.2 Global Custom Recombinant Antibody Conversion Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Custom Recombinant Antibody Conversion Service Key Company Headquarters & Area Served
  4. 5.4 Global Custom Recombinant Antibody Conversion Service Company, Product Type & Application
  5. 5.5 Global Custom Recombinant Antibody Conversion Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Custom Recombinant Antibody Conversion Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Custom Recombinant Antibody Conversion Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Custom Recombinant Antibody Conversion Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Creative Biolabs
  2. 6.1.1 Creative Biolabs Company Information
  3. 6.1.2 Creative Biolabs Business Overview
  4. 6.1.3 Creative Biolabs Custom Recombinant Antibody Conversion Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Creative Biolabs Custom Recombinant Antibody Conversion Service Product Portfolio
  6. 6.1.5 Creative Biolabs Recent Developments
  7. 6.2 Abnova Corporation
  8. 6.2.1 Abnova Corporation Company Information
  9. 6.2.2 Abnova Corporation Business Overview
  10. 6.2.3 Abnova Corporation Custom Recombinant Antibody Conversion Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Abnova Corporation Custom Recombinant Antibody Conversion Service Product Portfolio
  12. 6.2.5 Abnova Corporation Recent Developments
  13. 6.3 GenScript Biotech Corporation
  14. 6.3.1 GenScript Biotech Corporation Company Information
  15. 6.3.2 GenScript Biotech Corporation Business Overview
  16. 6.3.3 GenScript Biotech Corporation Custom Recombinant Antibody Conversion Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 GenScript Biotech Corporation Custom Recombinant Antibody Conversion Service Product Portfolio
  18. 6.3.5 GenScript Biotech Corporation Recent Developments
  19. 6.4 Rockland Immunochemicals Inc.
  20. 6.4.1 Rockland Immunochemicals Inc. Company Information
  21. 6.4.2 Rockland Immunochemicals Inc. Business Overview
  22. 6.4.3 Rockland Immunochemicals Inc. Custom Recombinant Antibody Conversion Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Rockland Immunochemicals Inc. Custom Recombinant Antibody Conversion Service Product Portfolio
  24. 6.4.5 Rockland Immunochemicals Inc. Recent Developments
  25. 6.5 LakePharma Inc.
  26. 6.5.1 LakePharma Inc. Company Information
  27. 6.5.2 LakePharma Inc. Business Overview
  28. 6.5.3 LakePharma Inc. Custom Recombinant Antibody Conversion Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 LakePharma Inc. Custom Recombinant Antibody Conversion Service Product Portfolio
  30. 6.5.5 LakePharma Inc. Recent Developments
  31. 6.6 ProteoGenix
  32. 6.6.1 ProteoGenix Company Information
  33. 6.6.2 ProteoGenix Business Overview
  34. 6.6.3 ProteoGenix Custom Recombinant Antibody Conversion Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 ProteoGenix Custom Recombinant Antibody Conversion Service Product Portfolio
  36. 6.6.5 ProteoGenix Recent Developments
  37. 6.7 ProMab Biotechnologies Inc.
  38. 6.7.1 ProMab Biotechnologies Inc. Company Information
  39. 6.7.2 ProMab Biotechnologies Inc. Business Overview
  40. 6.7.3 ProMab Biotechnologies Inc. Custom Recombinant Antibody Conversion Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 ProMab Biotechnologies Inc. Custom Recombinant Antibody Conversion Service Product Portfolio
  42. 6.7.5 ProMab Biotechnologies Inc. Recent Developments
  43. 6.8 Sino Biological Inc.
  44. 6.8.1 Sino Biological Inc. Company Information
  45. 6.8.2 Sino Biological Inc. Business Overview
  46. 6.8.3 Sino Biological Inc. Custom Recombinant Antibody Conversion Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Sino Biological Inc. Custom Recombinant Antibody Conversion Service Product Portfolio
  48. 6.8.5 Sino Biological Inc. Recent Developments
  49. 6.9 BOC Sciences
  50. 6.9.1 BOC Sciences Company Information
  51. 6.9.2 BOC Sciences Business Overview
  52. 6.9.3 BOC Sciences Custom Recombinant Antibody Conversion Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 BOC Sciences Custom Recombinant Antibody Conversion Service Product Portfolio
  54. 6.9.5 BOC Sciences Recent Developments
  55. 6.10 Absolute Antibody Ltd.
  56. 6.10.1 Absolute Antibody Ltd. Company Information
  57. 6.10.2 Absolute Antibody Ltd. Business Overview
  58. 6.10.3 Absolute Antibody Ltd. Custom Recombinant Antibody Conversion Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Absolute Antibody Ltd. Custom Recombinant Antibody Conversion Service Product Portfolio
  60. 6.10.5 Absolute Antibody Ltd. Recent Developments
  61. 6.11 OriGene Technologies Inc.
  62. 6.11.1 OriGene Technologies Inc. Company Information
  63. 6.11.2 OriGene Technologies Inc. Business Overview
  64. 6.11.3 OriGene Technologies Inc. Custom Recombinant Antibody Conversion Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 OriGene Technologies Inc. Custom Recombinant Antibody Conversion Service Product Portfolio
  66. 6.11.5 OriGene Technologies Inc. Recent Developments
  67. 6.12 Novus Biologicals LLC
  68. 6.12.1 Novus Biologicals LLC Company Information
  69. 6.12.2 Novus Biologicals LLC Business Overview
  70. 6.12.3 Novus Biologicals LLC Custom Recombinant Antibody Conversion Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Novus Biologicals LLC Custom Recombinant Antibody Conversion Service Product Portfolio
  72. 6.12.5 Novus Biologicals LLC Recent Developments
  73. 6.13 BioLegend Inc.
  74. 6.13.1 BioLegend Inc. Company Information
  75. 6.13.2 BioLegend Inc. Business Overview
  76. 6.13.3 BioLegend Inc. Custom Recombinant Antibody Conversion Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 BioLegend Inc. Custom Recombinant Antibody Conversion Service Product Portfolio
  78. 6.13.5 BioLegend Inc. Recent Developments
  79. 6.14 RayBiotech Inc.
  80. 6.14.1 RayBiotech Inc. Company Information
  81. 6.14.2 RayBiotech Inc. Business Overview
  82. 6.14.3 RayBiotech Inc. Custom Recombinant Antibody Conversion Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 RayBiotech Inc. Custom Recombinant Antibody Conversion Service Product Portfolio
  84. 6.14.5 RayBiotech Inc. Recent Developments
  85. 6.15 Proteintech Group Inc.
  86. 6.15.1 Proteintech Group Inc. Company Information
  87. 6.15.2 Proteintech Group Inc. Business Overview
  88. 6.15.3 Proteintech Group Inc. Custom Recombinant Antibody Conversion Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Proteintech Group Inc. Custom Recombinant Antibody Conversion Service Product Portfolio
  90. 6.15.5 Proteintech Group Inc. Recent Developments
  91. 6.16 ACROBiosystems
  92. 6.16.1 ACROBiosystems Company Information
  93. 6.16.2 ACROBiosystems Business Overview
  94. 6.16.3 ACROBiosystems Custom Recombinant Antibody Conversion Service Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 ACROBiosystems Custom Recombinant Antibody Conversion Service Product Portfolio
  96. 6.16.5 ACROBiosystems Recent Developments
7 North America
  1. 7.1 North America Custom Recombinant Antibody Conversion Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Custom Recombinant Antibody Conversion Service Market Size by Country (2021-2026)
  3. 7.3 North America Custom Recombinant Antibody Conversion Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Custom Recombinant Antibody Conversion Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Custom Recombinant Antibody Conversion Service Market Size by Country (2021-2026)
  3. 8.3 Europe Custom Recombinant Antibody Conversion Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Custom Recombinant Antibody Conversion Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Custom Recombinant Antibody Conversion Service Market Size by Country (2021-2026)
  3. 10.3 South America Custom Recombinant Antibody Conversion Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Custom Recombinant Antibody Conversion Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Custom Recombinant Antibody Conversion Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Custom Recombinant Antibody Conversion Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst